Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06510062 · ClinicalTrials.gov registry record · Phase 1
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
A Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06510062: Completed Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body, sponsored by ZetrOZ.
NCT06510062 is a Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body that has completed, run by ZetrOZ. The registered enrollment target is 67 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06510062, a Phase 1 study of Measurement of Circulation on Anatomical Locations of the Body, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
Primary Outcome
Blood Flow Flux through Upper Extremity (Perfusion Unit)
Conditions Studied
Interventions
- DRUG 2.5% Diclofenac Patches
- DEVICE Sustained Acoustic Medicine
Study Locations (1)
Connecticut
- ZetrOZ Systems LLC - Trumbull
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-07-22 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 1 |
What the finished NCT06510062 record still lists
NCT06510062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Measurement of Circulation on Anatomical Locations of the Body appearing as the primary indexed condition, and to 2 interventions - of which 2.5% Diclofenac Patches is the first listed.
NCT06510062 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06510062 about?
NCT06510062 is a clinical study titled "Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation". Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
What is the current status of trial NCT06510062?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2024-07-22. Estimated completion is 2024-12-31.
What conditions does trial NCT06510062 study?
This clinical trial studies the following conditions: Measurement of Circulation on Anatomical Locations of the Body.
What interventions are being tested in trial NCT06510062?
The interventions under investigation include: 2.5% Diclofenac Patches (DRUG), Sustained Acoustic Medicine (DEVICE).
Who is sponsoring clinical trial NCT06510062?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06510062 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06510062's enrollment target sits among peer trials
67 782nd of 2000 higher than 1,215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI